Over-expression of δC-DCLK-short in mouse brain results in a more anxious behavioral phenotype

Physiology and Behavior

Volumn 101, Issue 4, 2010, Pages 541-548

  Schenk, Geert J ^a   Veldhuisen, Barbera ^a   Wedemeier, Olga ^a   McGown, Caroline C ^a   Schouten, Theo G ^a   Oitzl, Melly ^a   de Kloet, E Ron ^a   Vreugdenhil, Erno ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Anxiety; DCLK; DCX; Elevated plus maze; GABA; Hippocampus; In situ hybridization; Transgenic mice

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DOUBLECORTIN; DOUBLECORTIN LIKE KINASE; MESSENGER RNA; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BEHAVIOR; BRAIN; BRAIN CORTEX; DOWN REGULATION; GABAERGIC TRANSMISSION; GENE OVEREXPRESSION; HIPPOCAMPUS; MAZE TEST; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYGDALA; ANIMALS; ANXIETY; BRAIN; CEREBRAL CORTEX; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; HIPPOCAMPUS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 77957241097     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.08.002     Document Type: Article

References (64)

1. Burgess H.A., Martinez S., Reiner O. KIAA0369, doublecortin-like kinase, is expressed during brain development. J Neurosci Res 1999, 58(4):567-575.
2. Lin P.T., Gleeson J.G., Corbo J.C., Flanagan L., Walsh C.A., et al. DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci 2000, 20(24):9152-9161.
3. Vreugdenhil E., Kolk S.M., Boekhoorn K., Fitzsimons C.P., Schaaf M., Schouten T., et al. Doublecortin-like, a microtubule-associated protein expressed in radial glia, is crucial for neuronal precursor division and radial process stability. Eur J Neurosci 2007, 25(3):635-648.
4. Schenk G.J., Engels B., Zhang Y.P., Fitzsimons C.P., Schouten T., Kruidering M., et al. A potential role for calcium/calmodulin-dependent protein kinase-related peptide in neuronal apoptosis: in vivo and in vitro evidence. Eur J Neurosci 2007, 26(12):3411-3420.
5. Vreugdenhil E., Datson N., Engels B., de Jong J., van Koningsbruggen S., Schaaf M., et al. Kainate-elicited seizures induce mRNA encoding a CaMK-related peptide: a putative modulator of kinase activity in rat hippocampus. J Neurobiol 1999, 39(1):41-50.
6. Burgess H.A., Reiner O. Alternative splice variants of doublecortin-like kinase are differentially expressed and have different kinase activities. J Biol Chem 2002, 277(20):17696-17705.
7. Friocourt G., Koulakoff A., Chafey P., Boucher D., Fauchereau F., Chelly J., et al. Doublecortin functions at the extremities of growing neuronal processes. Cereb Cortex 2003, 13(6):620-626.
8. Vreugdenhil E., Engels B., Middelburg R., van Koningsbruggen S., Knol J., Veldhuisen B., et al. Multiple transcripts generated by the DCAMKL gene are expressed in the rat hippocampus. Brain Res Mol Brain Res 2001, 94(1-2):67-74.
9. Kruidering M., Schouten T., Evan G.I., Vreugdenhil E. Caspase-mediated cleavage of the Ca2+/calmodulin-dependent protein kinase-like kinase facilitates neuronal apoptosis. J Biol Chem 2001, 276(42):38417-38425.
10. Koizumi H., Tanaka T., Gleeson J.G. Doublecortin-like kinase functions with doublecortin to mediate fiber tract decussation and neuronal migration. Neuron 2006, 49(1):55-66.
11. Deuel T.A., Liu J.S., Corbo J.C., Yoo S.Y., Rorke-Adams L.B., Walsh C.A. Genetic interactions between doublecortin and doublecortin-like kinase in neuronal migration and axon outgrowth. Neuron 2006, 49(1):41-53.
12. Tanaka T., Koizumi H., Gleeson J.G. The doublecortin and doublecortin-like kinase 1 genes cooperate in murine hippocampal development. Cereb Cortex 2006, 16(Suppl 1):i69-i73.
13. Tuy F.P., Saillour Y., Kappeler C., Chelly J., Francis F. Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice. Dev Neurosci 2008, 30(1-3):171-186.
14. Sapir T., Horesh D., Caspi M., Atlas R., Burgess H.A., Wolf S.G., et al. Doublecortin mutations cluster in evolutionarily conserved functional domains. Hum Mol Genet 2000, 9(5):703-712.
15. Hevroni D., Rattner A., Bundman M., Lederfein D., Gabarah A., Mangelus M., et al. Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms. J Mol Neurosci 1998, 10(2):75-98.
16. Silverman M.A., Benard O., Jaaro H., Rattner A., Citri Y., Seger R. CPG16, a novel protein serine/threonine kinase downstream of cAMP-dependent protein kinase. J Biol Chem 1999, 274(5):2631-2636.
17. Dijkmans T.F., van Hooijdonk L.W., Schouten T.G., Kamphorst J.T., Fitzsimons C.P., Vreugdenhil E. Identification of new Nerve Growth Factor-responsive immediate-early genes. Brain Res 2009, 1249:19-33.
18. Dijkmans T.F., van Hooijdonk L.W., Fitzsimons C.P., Vreugdenhil E. The doublecortin gene family and disorders of neuronal structure. Cent Nerv Syst Agents Med Chem. 2010, 10(1):32-46.
19. Engels B.M., Schouten T.G., van Dullemen J., Gosens I., Vreugdenhil E. Functional differences between two DCLK splice variants. Brain Res Mol Brain Res 2004, 120(2):103-114.
20. Ohmae S., Takemoto-Kimura S., Okamura M., Adachi-Morishima A., Nonaka M., Fuse T., et al. Molecular identification and characterization of a family of kinases with homology to Ca2+/calmodulin-dependent protein kinases I/IV. J Biol Chem 2006, 281(29):20427-20439.
21. Pedotti P., t Hoen P.A., Vreugdenhil E., Schenk G.J., Vossen R.H., Ariyurek Y., et al. Can subtle changes in gene expression be consistently detected with different microarray platforms?. BMC Genomics 2008, 9:124.
22. t Hoen P.A., Ariyurek Y., Thygesen H.H., Vreugdenhil E., Vossen R.H., de Menezes R.X., et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res 2008, 36(21):e141.
23. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., et al. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999, 2(9):833-839.
24. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999, 401(6755):796-800.
25. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290(5489):131-134.
26. Atack J.R. The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Expert Opin Investig Drugs 2005, 14(5):601-618.
27. Rudolph U., Mohler H. GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 2006, 6(1):18-23.
28. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996, 54(1):21-30.
29. Rodgers R.J., Dalvi A. Anxiety, defence and the elevated plus-maze. Neurosci Biobehav Rev 1997, 21(6):801-810.
30. Rodgers R.J., Cao B.J., Dalvi A., Holmes A. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997, 30(3):289-304.
31. Vidal M., Morris R., Grosveld F., Spanopoulou E. Tissue-specific control elements of the Thy-1 gene. EMBO J 1990, 9(3):833-840.
32. Moechars D., Lorent K., De Strooper B., Dewachter I., Van Leuven F. Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J 1996, 15(6):1265-1274.
33. Meijer O.C., Steenbergen P.J., De Kloet E.R. Differential expression and regional distribution of steroid receptor coactivators SRC-1 and SRC-2 in brain and pituitary. Endocrinology 2000, 141(6):2192-2199.
34. Franklin K.B.J.a.P.G. The mouse brain in stereotaxic coordinates 1997, Academic Press.
35. Boekhoorn K., Sarabdjitsingh A., Kommerie H., de Punder K, Schouten T., Lucassen P.J., et al. Doublecortin (DCX) and doublecortin-like (DCL) are differentially expressed in the early but not late stages of murine neocortical development. J Comp Neurol 2008, 507(4):1639-1652.
36. Brinks V., van der Mark M., de Kloet R., Oitzl M. Emotion and cognition in high and low stress sensitive mouse strains: a combined neuroendocrine and behavioral study in BALB/c and C57BL/6J mice. Front Behav Neurosci 2007, 1:8.
37. Friocourt G., Liu J.S., Antypa M., Rakic S., Walsh C.A., Parnavelas J.G. Both doublecortin and doublecortin-like kinase play a role in cortical interneuron migration. J Neurosci 2007, 27(14):3875-3883.
38. Whiting P.J. GABA-A receptors: a viable target for novel anxiolytics?. Curr Opin Pharmacol 2006, 6(1):24-29.
39. Mohler H., Fritschy J.M., Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002, 300(1):2-8.
40. Engin E., Treit D. The role of hippocampus in anxiety: intracerebral infusion studies. Behav Pharmacol 2007, 18(5-6):365-374.
41. Kalueff A.V., Tuohimaa P. Grooming analysis algorithm for neurobehavioural stress research. Brain Res Brain Res Protoc 2004, 13(3):151-158.
42. Augustsson H., Meyerson B.J. Exploration and risk assessment: a comparative study of male house mice (Mus musculus musculus) and two laboratory strains. Physiol Behav 2004, 81(4):685-698.
43. Flint J., Corley R., DeFries J.C., Fulker D.W., Gray J.A., Miller S., et al. A simple genetic basis for a complex psychological trait in laboratory mice. Science 1995, 269(5229):1432-1435.
44. Dawson G.R., Collinson N., Atack J.R. Development of subtype selective GABAA modulators. CNS Spectr 2005, 10(1):21-27.
45. Papadopoulos T., Korte M., Eulenburg V., Kubota H., Retiounskaia M., Harvey R.J., et al. Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J 2007, 26(17):3888-3899.
46. Mohler H., Fritschy J.M., Vogt K., Crestani F., Rudolph U. Pathophysiology and pharmacology of GABA(A) receptors. Handb Exp Pharmacol 2005, 169:225-247.
47. Tozuka Y., Fukuda S., Namba T., Seki T., Hisatsune T. GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron 2005, 47(6):803-815.
48. Ge S., Pradhan D.A., Ming G.L., Song H. GABA sets the tempo for activity-dependent adult neurogenesis. Trends Neurosci 2007, 30(1):1-8.
49. Ganguly K., Schinder A.F., Wong S.T., Poo M. GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 2001, 105(4):521-532.
50. Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 2002, 3(9):728-739.
51. Shang L., Kwon Y.G., Nandy S., Lawrence D.S., Edelman A.M. Catalytic and regulatory domains of doublecortin kinase-1. Biochemistry 2003, 42(7):2185-2194.
52. Izquierdo I., Medina J.H. Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 1997, 68(3):285-316.
53. Kouzu Y., Moriya T., Takeshima H., Yoshioka T., Shibata S. Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus. Brain Res Mol Brain Res 2000, 76(1):142-150.
54. Ahi J., Radulovic J., Spiess J. The role of hippocampal signaling cascades in consolidation of fear memory. Behav Brain Res 2004, 149(1):17-31.
55. Blaeser F., Sanders M.J., Truong N., Ko S., Wu L.J., Wozniak D.F., et al. Long-term memory deficits in Pavlovian fear conditioning in Ca2+/calmodulin kinase kinase alpha-deficient mice. Mol Cell Biol 2006, 26(23):9105-9115.
56. Papaleo F., Crawley J.N., Song J., Lipska B.K., Pickel J., Weinberger D.R., et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci 2008, 28(35):8709-8723.
57. Moser M.B., Moser E.I. Functional differentiation in the hippocampus. Hippocampus 1998, 8(6):608-619.
58. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004, 28(3):273-283.
59. McHugh S.B., Deacon R.M., Rawlins J.N., Bannerman D.M. Amygdala and ventral hippocampus contribute differentially to mechanisms of fear and anxiety. Behav Neurosci 2004, 118(1):63-78.
60. Trivedi M.A., Coover G.D. Lesions of the ventral hippocampus, but not the dorsal hippocampus, impair conditioned fear expression and inhibitory avoidance on the elevated T-maze. Neurobiol Learn Mem 2004, 81(3):172-184.
61. Esclassan F., Coutureau E., Di Scala G., Marchand A.R. Differential contribution of dorsal and ventral hippocampus to trace and delay fear conditioning. Hippocampus 2009, 19(1):33-44.
62. Treit D., Pesold C., Rotzinger S. Noninteractive effects of diazepam and amygdaloid lesions in two animal models of anxiety. Behav Neurosci 1993, 107(6):1099-1105.
63. Sommer W., Moller C., Wiklund L., Thorsell A., Rimondini R., Nissbrandt H. Local 5,7-dihydroxytryptamine lesions of rat amygdala: release of punished drinking, unaffected plus-maze behavior and ethanol consumption. Neuropsychopharmacology 2001, 24(4):430-440.
64. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav Neurosci 1997, 111(3):653-658.